433
Views
24
CrossRef citations to date
0
Altmetric
SPECIAL CONTRIBUTIONS

P REHOSPITAL T HERAPY FOR A CUTE C ONGESTIVE H EART F AILURE : S TATE OF THE A RT

, , &
Pages 13-23 | Published online: 02 Jul 2009

References

  • Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med. 1999;159: 505–10.
  • Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628–40.
  • Hunt SA, Baker DW, Chin MH, et al. ACC / AHA guidelines for the evalua-tion and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guide-lines for the Evaluation and Manage-ment of Heart Failure). J Am Coll Cardiol. 2001;38: 2101–13.
  • Cotter G. Moshkovitz Y, Milovanov 0, et al. Acute heart failure: a novel approach to its pathogenesis and treat-ment. Eur J Heart Fail. 2002; 4: 227–34.
  • Gardtman M, Waagstein L, Karlsson T, Herlitz J. Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the out-come? Eur J Emerg Med. 2000;7:15–24.
  • Bertini G, Giglioli C, Biggeri A, et al. Intravenous nitrates in the prehospital management of acute pulmonary edema. Ann Emerg Med. 1997;30:493–9.
  • Guntupalli KK. Acute pulmonary edema. Cardiol Clin. 1984;2:183–200.
  • Marx J, Hockberger R, Walls R. Rosen's Emergency Medicine: Concepts and Clinical Practice, 5th ed. St. Louis, MO: Mosby, 2002.
  • Cecil RL, Bennett JC, Goldman L. Cecil Textbook of Medicine, 21st ed. Philadel-phia, PA: W. B. Saunders Company, 1999.
  • Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furose-mide in treatment of presumed prehos-pital pulmonary edema. Chest. 1987; 92:586–93.
  • Kosowsky JIM, Stephanides SL, Branson RD, Sayre MR. Prehospital use of con-tinuous positive airway pressure (CPAP) for presumed pulmonary edema: a pre-liminary case series. Prehosp Emerg Care. 2001;5:190–6.
  • Sacchetti AD, Harris RH. Acute cardio-genic pulmonary edema. What's the lat-est in emergency treatment? Postgrad Med. 1998;103:145–66.
  • Cotter G, Kaluski E, Moshkovitz Y, Milovanov 0, Krakover R, Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Curr Opin Cardiol. 2001;16: 159–63.
  • Mulrow C, Lucey C, Farnett L. Dis-criminating causes of dyspnea through the clinical examination. J Gen Intern Med. 1993;8:383–92.
  • Schmitt B, Kushner M, Wiener S. The diagnostic usefulness of history of the patient with dyspnea. J Gen Intern Med. 1986;1:386–93.
  • Little B, Ho KJ, Scott L. Electrocardio-gram and rhythm strip interpretation by final year medical students. Ulster Med J. 2001;70:108–10.
  • Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002:347:161–7.
  • Maisel A. B-type natriuretic peptide in the diagnosis and management of con-gestive heart failure. Cardiol Clin. 2001;19:557–71.
  • Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic pep-tide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379–85.
  • Morrison LK, Harrison A, Krishna-swamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating conges-tive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202–9.
  • Tabbibizar R, Maisel A. The impact of B-type natriuretic peptide levels on the diagnosis and management of conges-tive heart failure. Curr Opin Cardiol. 2002;17:340–5.
  • Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic pep-tide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail. 2002;8:149–54.
  • Ventura HO, Pranulis MF, Young C, Smart FW. Impedance cardiography: a bridge between research and clinical practice in the treatment of heart failure. Congest Heart Fail. 2000;6:94–102.
  • Kukovetz WR, Holzmann S. Mech-anisms of nitrate-induced vasodilation and tolerance. Eur J Clin Pharmacol. 1990;38\(suppl 1):59–514.
  • Sacchetti A, Ramoska E, Moakes ME, McDermott P, Moyer V. Effect of ED management on ICU use in acute pul-monary edema. Am J Emerg Med. 1999;7:571–4.
  • Packer M. Neurohormonal interactions and adaptations in congestive heart fail-ure. Circulation. 1988;77:721–30.
  • Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosor-bide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pul-monary oedema. Lancet. 1998;351:389–93.
  • Wuerz R, Swope G, Meador S, Holliman CJ, Roth GS. Safety of prehos-pital nitroglycerin. Ann Emerg Med. 1994;23:31–6.
  • Wuerz RC, Meador SA. Effects of pre-hospital medications on mortality and length of stay in congestive heart fail-ure. Ann Emerg Med. 1992;21:669–74.
  • Dorthridge D. Fumsemide or nitrates for acute heart failure? Lancet. 1996;347: 667–8.
  • Barnett J, Zink KM, Touchon RC. Sublingual captopril in the treatment of acute heart failure. Curr Ther Res. 1991;49:274–81.
  • Leeman M, Deguate JP. Invasive hemo-dynamic evaluation of sublingual cap-topril and nifedipine in patients with arterial hypertension after abdominal aortic surgery. Crit Care Med. 1995;23: 847–7.
  • Hamilton RJ, Carter WA, Gallagher EJ. Rapid improvement of acute pul-monary edema with sublingual capto-pril. Acad Emerg Med. 1996;3:205–12.
  • Ahmed A. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc. 2002;50:1293–6.
  • Langes K, Siebels J, Kuck KH. Efficacy and safety of intravenous captopril in congestive heart failure. Curr Ther Res. 1993;53:167–76.
  • Annane D, Bellissant E, Pussard E, et al. Placebo-controlled, randomized, dou-ble-blind study of intravenous enalapri-lat efficacy and safety in acute cardio-genic pulmonary edema. Circulation. 1996;94:1316–24.
  • Podbregar M, Voga G, Horvat M, et al. Bolus versus continuous low dose of enalaprilat in congestive heart failure with acute refractory decompensation. Cardiology. 1999;91(1):41–9.
  • Colucci WS. Nesiritide for the treatment of decompensated heart failure. J Card Fail. 2001;7:92–100.
  • Pingleton SK. Complications of acute respiratory failure. Am Rev Respir Dis. 1988;137:1463–93.
  • Colice GL, Stukel TA, Dain B. Laryngeal complications of prolonged intubation. Chest. 1989;96:877–84.
  • Craven DE, Steger KA. Epidemiology of nosocomial pneumonia: new perspec-tives on an old disease. Chest. 1995; 108(2 suppl):1S–165.
  • Schnapp LM, Chin DP, Szaflarski N, Matthay MA. Frequency and impor-tance of bamtrauma in 100 patients with acute lung injury. Crit Care Med. 1995;23:272–8.
  • Meduri GU, Turner RE, Abou-Shala N. Noninvasive positive pressure ventila-tion via face mask: first-line interven-tion in patients with acute hypercapnic and hypoxemic respiratory failure. Chest. 1996;109:179–93.
  • Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333:817–22.
  • Bersten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ. Treatment of severe cardiogenic pul-monary edema with continuous posi-tive airway pressure delivered by face mask. N Engl J Med. 1991;325: 1825–30.
  • Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med. 1995;151: 1799–806.
  • Meduri GU, Cook TR, Turner RE, Cohen M, Leeper KV. Noninvasive positive pressure ventilation in status asth-maticus. Chest. 1996;110:767–74.
  • Meduri GU, Conoscenti CC, Menashe P, Nair S. Noninvasive face mask ventila-tion in patients with acute respiratory failure. Chest. 1989;95:865–70.
  • Pennock BE, Crashaw L, Kaplan PD. Noninvasive nasal mask ventilation for acute respiratory failure: institution of a new therapeutic technology for routine use. Chest. 1994;105:441–4.
  • Baratz DM, Westbrook PR, Shah PK, Mohsenifar Z. Effect of nasal continu-ous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure. Chest. 1992;102:1397–401.
  • Sacchetti AD, Harris RH, Paston C, Hernandez Z. Bi-level positive airway pressure support system use in acute congestive heart failure: preliminary case series. Acad Emerg Med. 1995;2:714–8.
  • Pollack C Jr, Torres MT, Alexander L. Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department. Ann Emerg Med. 1996;27:189–92.
  • Kosowsky JIM, Storrow AB, Carleton SC. Continuous and bilevel positive airway pressure in the treatment of acute car-diogenic pulmonary edema. Am J Emerg Med. 2000;18:91–5.
  • Rasanen J, Heikkila J, Downs J, Nikki P, Vaisanen I, Viitanen A. Continuous pos-itive airway pressure by face mask in acute cardiogenic pulmonary edema. Am J Cardiol. 1985;55:296–300.
  • Lin M, Chiang HT. The efficacy of early continuous positive airway pressure therapy in patients with acute cardio-genic pulmonary edema. J Formos Med Assoc. 1991;90:736–43.
  • Takeda S, Nejima J, Takano T, et al. Effect of nasal continuous positive air-way pressure on pulmonary edema complicating acute myocardial infarc-tion. Jpn Circ J. 1998;62:553–8.
  • Pang D, Keenan SP, Cook DJ, Sibbald VVJ. The effect of positive pressure air-way support on mortality and the need for intubation in cardiogenic pul-monary edema: a systematic review. Chest. 1998;114:1185–92.
  • Kelly AM, Georgakas C, Bau S, Rosengarten P. Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency man-agement of acute severe cardiogenic pulmonary oedema. Aust N Z J Med. 1997;27:319–22.
  • Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med. 1997; 25:1685–92.
  • Mehta S, Jay GD, Woolard RH, et al. Randomized, prospective trial of bilevel versus continuous positive airway pres-sure in acute pulmonary edema. Crit Care Med. 1997;25:620–8.
  • Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998; 339: 429–35.
  • Masip J, Betbese AJ, Paez J, et al. Noninvasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet. 2000;356:2126–32.
  • Sharon A, Shpirer I, Kaluski E, et al. High-dose intravenous isosorbide-dini-trate is safer and better than Bi-PAP ven-tilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol. 2000;36:832–7.
  • Levitt MA. A prospective, randomized trial of BiPAP in severe acute congestive heart failure. J Emerg Med. 2001;21:363–9.
  • Craven RA, Singletary N, Bosken L, Sewell E, Payne M, Lipsey R. Use of bilevel positive airway pressure in out-of-hospital patients. Acad Emerg Med. 2000;7:1065–8.
  • Wilkes MS, Middlekauff H, Hoffman JR. Heart failure: Part II. West J Med. 1999; 170:339–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.